hsa-mir-132 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780CP20) |
hsa-mir-132 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CP20) |
hsa-mir-132 |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CIS) |
hsa-mir-132 |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A549) |
hsa-mir-132 |
Androstenedione+Letrozole |
|
|
|
sensitive |
|
|
|
cell line (MCF-7) |
hsa-mir-132 |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (BxPC3) |
hsa-mir-132 |
Ceritinib |
57379345 |
NSC776422 |
approved |
sensitive |
|
|
|
cell line (H3122) |
hsa-miR-132-3p |
(1Z)-2-anilino-N-[(5-carbamoyl-1H-imidazol-4-yl)amino]-2-oxoethanimidoyl cyanide |
5466279 |
NSC683605 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
(2Z)-2-(tert-butylhydrazinylidene)-N-(3-chloro-1,4-dioxonaphthalen-2-yl)-3-(3,7,12-trioxo-4H-naphtho[2,3-h]quinoxalin-2-yl)propanamide |
5479912 |
NSC649574 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
(7-acetamido-2-acetyloxy-1-methoxy-10-methylsulfanyl-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-3-yl) acetate |
435732 |
NSC374980 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
(e)-1-(benzenesulfonyl)-3-(2-phenyl-1h-indol-3-yl)prop-2-en-1-one |
54613416 |
NSC749193 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
(E)-3-[3,5-bis(trifluoromethyl)phenyl]sulfanyl-1-(4-chlorophenyl)prop-2-en-1-one |
6181983 |
NSC735169 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
(Z)-3-[5-[3,5-bis(trifluoromethyl)phenyl]furan-2-yl]prop-2-enenitrile |
5468615 |
NSC672868 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
(z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9h-purine |
60147744 |
NSC752329 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
[(5s,8ar,9r)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[5,6-f][1,3]benzodioxol-5-yl] 3-aminobenzoate |
|
NSC642276 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
[3,4,5-triacetyloxy-6-(3-cyano-6-phenyl-2-sulfanyl-4-thiophen-2-yl-4h-pyridin-1-yl)oxan-2-yl]methyl acetate |
381303 |
NSC667740 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
1-(2-thiazoylazo)-2-naphthol |
93572 |
NSC139021 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
1-(4-methoxyphenyl)-3-[(z)-1-[6-[(z)-n-[(4-methoxyphenyl)carbamothioylamino]-c-methylcarbonimidoyl]pyridin-2-yl]ethylideneamino]thiourea |
6375828 |
NSC668486 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
1-(6,7-dichloro-1-(4-chlorophenyl)-1h-pyrazolo[3,4-b]quinoxalin-3-yl)-1,2,3,4-butanetetrol |
365567 |
NSC633362 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
1-(acetyloxy)-2-(2-(1-(acetyloxy)-1h-benzimidazol-2-yl)phenyl)-1h-benzimidazole |
355531 |
NSC609356 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide |
24181037 |
NSC4290 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
10-nitrosophenanthren-9-ol |
95223 |
NSC48526 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
12-imino-4,10,14,20-tetrazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(13),3(11),9,19-tetraen-2-one |
46861729 |
NSC753790 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
15-benzyl-9-pyridin-3-yl-15-azatetracyclo[8.6.1.02,7.014,17]heptadeca-1(16),2,4,6,10(17),11,13-heptaen-8-one |
57409953 |
NSC762458 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-((5-methyl-3-isoxazolyl)amino)-4-((5-methyl-3-isoxazolyl)imino)-1(4h)-naphthalenone |
373420 |
NSC649750 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-(3-chloropropyloxy)naphthazarin |
378771 |
NSC661941 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-(4-methylphenyl)-5-phenyl-1h-[1,2,4]triazino[4,3-a]quinoxaline |
399104 |
NSC709520 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
2-(6-benzoyl-1h-benzimidazol-2-yl)-3,4,5,6-tetrachloro-n-(furan-2-yl)benzamide |
402231 |
NSC716122 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-(diethylamino)ethyl (E)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)prop-2-enoate |
5388753 |
NSC638408 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-(furan-2-yl)-5-phenyl-1h-pyrazolo[1,5-a]pyrimidin-7-one |
342597 |
NSC379651 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-[(e)-[[1-(4-chlorophenyl)-3-methylpyrazolo[3,4-d]pyrimidin-4-yl]hydrazinylidene]methyl]phenol |
136040127 |
NSC753018 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
2-[(z)-6-[2-(trifluoromethyl)phenyl]hex-3-en-1,5-diynyl]aniline |
24203959 |
NSC730269 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-amino-4-cyclopropyl-6-(4-fluorophenyl)cyclohexa-2,4-diene-1,1,3-tricarbonitrile |
400138 |
NSC711632 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-amino-9-chloro-3,5-bis(4-chlorophenyl)pyrimido[4,5-c]quinolin-1-one |
16126264 |
NSC741296 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
2-amino-N-[4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl]acetamide |
284708 |
NSC140873 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-bromo-1-[6-(2-bromopyridin-1-ium-1-yl)naphthalen-2-yl]pyridin-1-ium;bromide |
54608313 |
NSC129757 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
2-methoxy-5h-pyrido[3,2:4,5]pyrrolo[3,2-c]cinnoline |
54613488 |
NSC749296 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
2-methylthieno[3,2-f][1]benzothiole-4,8-dione |
375901 |
NSC656238 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-nitro-3-phenylspiro[cyclopropane-1,9'-fluorene] |
282082 |
NSC135168 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2-oxo-n-(pyridin-4-yl)-2-(1-tosyl-1h-indol-3-yl)acetamide |
155814544 |
NSC758357 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2,3,10,11-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-8-one |
392605 |
NSC693145 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
2,5,11-trimethyl-9-phenoxy-6h-pyrido[4,3-b]carbazol-2-ium;acetate |
10431819 |
NSC650269 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
2,6-bis[1-(3-ethylthioureidoimino)ethyl]pyridine |
6393657 |
NSC668337 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
3-(3,5-dibromo-4-methoxyphenyl)-2-(3-pyridinyl)acrylonitrile |
5467796 |
NSC659319 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-(3,5-dichlorophenyl)-2-(2-pyridinyl)acrylonitrile |
5467799 |
NSC659323 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-[(2,3-dimethoxyphenyl)methyl]-7,8-dimethoxy-5-methylsulfanyl-2,5-dihydro-1H-3-benzazepin-4-one |
359177 |
NSC619859 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-[(E)-[(4-nitrophenyl)hydrazinylidene]methyl]-1H-benzo[g]quinoxaline-2,5,10-trione |
135436193 |
NSC713198 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-[(Z)-[1-(3,4,5-trimethoxyphenyl)pyrido[3,4-b]indol-3-ylidene]methyl]-1H-indol-2-ol |
155808310 |
NSC761816 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-[(Z)-[1-(3,5-dimethoxyphenyl)pyrido[3,4-b]indol-3-ylidene]methyl]-5-methoxy-1H-indol-2-ol |
155813091 |
NSC761832 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-[[3-(furan-2-carbonyl)-2-sulfanylideneimidazolidin-1-yl]methylidene]pentane-2,4-dione |
24203787 |
NSC729519 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
3-[5-(4-amino-2,6-dibromophenyl)-1,3,4-oxadiazol-2-yl]-1-(1H-benzimidazol-2-yl)propan-1-one |
71451481 |
NSC761980 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-[6-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)hexyl]-5,5-diphenylimidazolidine-2,4-dione |
343242 |
NSC382386 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
3-amino-N-(2-fluorophenyl)-5-oxo-7,8-dihydro-6H-thieno[2,3-b]quinoline-2-carboxamide |
1856915 |
NSC754567 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-(4,7-dimethoxy-1,3-benzodioxol-5-yl)-5-(4-methoxyphenyl)-2H-triazole |
73334660 |
NSC763198 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[(13R)-13-hydroxy-13-[(2S,5S)-5-[(2S,5S)-5-[1-hydroxy-13-[(2S)-2-methyl-5-oxo-2H-furan-4-yl]tridecyl]oxolan-2-yl]oxolan-2-yl]tridecyl]-2-methyl-2H-furan-5-one |
374064 |
NSC651320 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[(2Z)-2-[1-amino-3-(methylamino)-1,3-bis(sulfanylidene)propan-2-ylidene]hydrazinyl]-1H-imidazole-5-carboxamide |
5466293 |
NSC684046 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
4-[(e)-(9-ethylcarbazol-3-yl)azo]benzonitrile |
394667 |
NSC698269 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]quinoline |
6285127 |
NSC87197 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione |
5781544 |
NSC642968 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[[(Z)-N-benzamido-C-[4-[bis(2-cyanoethyl)amino]-2-methylphenyl]carbonimidoyl]diazenyl]benzoic acid |
135493923 |
NSC681974 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[2-[2-(4-carbamimidoylanilino)ethoxy]ethylamino]benzenecarboximidamide;hydrochloride |
24206088 |
NSC740025 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[4-(diethylamino)benzenecarboximidoyl]-n,n-dimethylaniline;hydrochloride |
|
NSC33566 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-[4,6-bis(methylsulfanyl)pyrazolo[3,4-d]pyrimidin-1-yl]-7-chloroquinoline |
24203467 |
NSC728188 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-methylsulfanyl-N-[(3,4,5-trimethoxyphenyl)methyl]aniline |
373808 |
NSC650772 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4-methylthio-n-(3,4,5-trimethoxybenzyl)aniline |
373808 |
NSC650771 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
4,5-bis(4-methoxyphenyl)-1h-imidazol-2(5h)-one |
231112 |
NSC26692 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
5-[2-(3-hydroxy-4-methoxyphenyl)ethynyl]-6-(3,4,5-trimethoxyphenyl)pyran-2-one |
45028148 |
NSC741289 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
5-bromo-3h-triazolo[4,5-d]pyrimidin-7-ol |
135440019 |
NSC680827 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
5-hydroxy-10-methoxy-1-methylbenzo[g]quinolin-4(1h)-one |
406554 |
NSC724702 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
5-methylphenanthroline |
72791 |
NSC4272 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
5,10-dimethoxybenzo[g]quinolin-2(1h)-one |
54612875 |
NSC750104 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
6-butyl-12-methyl-5,6-dihydrobenzimidazolo[2,1-a]isoquinolin-7-ium-3,10-diol;6-butyl-12-methyl-5,6-dihydrobenzimidazolo[2,1-a]isoquinolin-12-ium-3,9-diol;diiodide |
403475 |
NSC718370 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
7-[(1-hydroxy-1-phenylpropan-2-yl)amino]quinoline-5,8-dione |
386231 |
NSC677949 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
7-[(3,4-dimethoxyphenyl)methyl]-6-phenyl-4,5-dihydropyrrolo[3,4-g][1,2]benzoxazole |
60148271 |
NSC754077 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
8-azadenosine |
251928 |
NSC72961 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
9-methyl-2-[4-(4-phenylpiperazin-1-yl)butyl]-3,4-dihydropyrido[3,4-b]indol-1-one |
365677 |
NSC633530 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Acetonitrile;carbon monoxide;dibromoosmium;triphenylphosphane |
498712 |
NSC634761 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Antineoplastic-642316 |
369949 |
NSC642316 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
B1a8bpf5u8 |
72574 |
NSC84167 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- |
353644 |
NSC602617 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Benzyl 4-[(3,6-dioxocyclohexa-1,4-dien-1-yl)methylamino]benzoate |
386492 |
NSC678636 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Bindschedler's green |
73516 |
NSC7811 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Chlorotriethyltin |
13820 |
NSC5283 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Chrome black t |
3246023 |
NSC7223 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Cinnoline, 4-nitro-, 1-oxide |
100397 |
NSC294846 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Dezaguanine |
55710 |
NSC261726 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) |
368297 |
NSC638842 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Dimethyl 1-[(z)-2-[(z)-1,4-dimethoxy-1,4-dioxobut-2-en-2-yl]sulfanyl-1,2-bis(4-methoxyphenyl)ethenyl]pyrazole-3,4-dicarboxylate |
5471659 |
NSC712735 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Erlotinib |
176870 |
NSC718781 |
approved |
resistant |
|
|
|
|
hsa-miR-132-3p |
Ethanol, 2-[4-(2,2':6',2"-terpyridin-4'-yl)phenoxy]- |
368990 |
NSC640499 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Ethanone, 1-(2-pyrimidinyl)-, (2-benzoxazolyl)hydrazone |
9572051 |
NSC693639 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Ethaverine hydrochloride |
5702159 |
NSC757818 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Fluorene, 9-bromo-2,4,7-trichloro- |
248608 |
NSC65921 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Gardenin b |
96539 |
NSC79093 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Gw693881a |
44571452 |
NSC756316 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Hedamycin |
98033 |
NSC70929 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Hymenialdisine |
135413546 |
NSC607173 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Ls-94160 |
135408599 |
NSC52426 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Megxp0_000612 |
5386961 |
NSC618932 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Methyl (1s,10r)-6-methyl-10-nonyl-7,9,12-triazatricyclo[6.3.1.04,12]dodeca-5,8-diene-5-carboxylate |
401693 |
NSC715423 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Methyl (2e)-2-[(1r,7r,10s,12r)-14-acetamido-7,14-dimethyl-4-oxo-6-azatetracyclo[8.3.1.02,6.07,12]tetradec-2-en-5-ylidene]acetate |
5470606 |
NSC703547 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Methyl 2-(4,6-dimethyl-3-oxospiro[1h-indene-2,5'-3,4-dihydropyrazole]-4'-yl)benzoate |
386181 |
NSC677803 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Methyl 2-[[4,6-bis[hydroxy(methyl)amino]-1,3,5-triazin-2-yl]amino]acetate |
45029484 |
NSC746930 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Methyl 2-[2-[3-hydroxy-3-(2-methoxy-2-oxo-ethyl)indol-2-yl]-1h-indol-3-yl]acetate |
392215 |
NSC692348 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Methyl 4-[3-(2-thienyl)quinoxalin-2-yl]oxybenzoate |
388002 |
NSC682365 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Methyl 6-[[(3S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-8a-[3-[4-[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-6-methyl-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxycarbonyl-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3, |
385536 |
NSC676794 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Methyl n-[6-(methoxycarbonylamino)pyren-1-yl]carbamate;methyl n-[8-(methoxycarbonylamino)pyren-1-yl]carbamate |
|
NSC33092 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Michler's thione |
71045 |
NSC30656 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Miltefosin c |
3599 |
NSC605583 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Mitomycin c,methylamine fr. streptomyces caespitosus |
213803 |
NSC329086 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
N'-(4-chlorobenzoyl)-n-[(e)-1-(2-hydroxyphenyl)ethylideneamino]-n'-(4-methylphenyl)propanediamide |
135499196 |
NSC644474 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-(1,3-benzothiazol-2-yl)-2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidine-5-carboxamide |
71624130 |
NSC763635 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
N-(2,3-dimethyl-7-nitroquinolin-4-yl)-N',N'-dimethylpropane-1,3-diamine;hydrochloride |
372712 |
NSC648273 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
N-(4-aziridinylbutyl)-1,3-diaminopropane |
160395 |
NSC658397 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-(6-methyl-1,3-benzothiazol-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1h-2-benzofuran-1-yl)butanamide |
369455 |
NSC641225 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
N-[(e)-(2,4-dihydroxyphenyl)methylideneamino]-3-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide |
135968269 |
NSC748262 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[(E)-(2,4-dihydroxyphenyl)methylideneamino]-8-ethoxy-4-hydroxy-1-oxo-6-phenyl-2H-2,7-naphthyridine-3-carboxamide |
135968282 |
NSC747284 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[(e)-(5-chloro-2-hydroxyphenyl)methylideneamino]-2-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide |
135968273 |
NSC747459 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[(e)-[4-(diethylamino)-2-hydroxyphenyl]methylideneamino]-2-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide |
135968272 |
NSC747458 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[(e)-[4-(diethylamino)-2-hydroxyphenyl]methylideneamino]-4-[[2-(trifluoromethyl)pyridin-4-yl]amino]benzamide |
135968274 |
NSC747460 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[(E)-1-(6-methylpyridin-2-yl)ethylideneamino]-3-azabicyclo[3.2.2]nonane-3-carbothioamide |
5464837 |
NSC335789 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[(Z)-[[4-[bis(2-cyanoethyl)amino]-2-methylphenyl]-[(4-methoxyphenyl)diazenyl]methylidene]amino]benzamide |
135493921 |
NSC681972 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
N-[2-(hydrazinecarbonyl)-4-nitrophenyl]adamantane-1-carboxamide |
5472393 |
NSC718359 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[3-[2-[(7-chloroquinolin-4-yl)amino]ethyl-ethylamino]propyl]-2-[7-(dimethylamino)-2-oxochromen-4-yl]acetamide |
49856402 |
NSC754328 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
N-[4-[(2-methoxy-11-oxo-6a,7,8,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl)oxy]butyl]-1h-indole-2-carboxamide |
20826874 |
NSC726365 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
N-[4-[hydroxy(methyl)amino]-6-(propylamino)-1,3,5-triazin-2-yl]-n-methylhydroxylamine |
45029482 |
NSC746928 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Naphth[2,3-d]oxazol-9-one, 2-methyl-4-(phenylimino)- |
160386 |
NSC650573 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Naphthalene-1,2-dione, 1,2-dihydro-4-[(3-pyridinyl)amino]- |
367787 |
NSC637729 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Neuro_000310 |
368991 |
NSC640500 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Pan (van) |
6825 |
NSC5332 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Questiomycin a |
72725 |
NSC94945 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Resorufin |
69462 |
NSC12097 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
S-(3,5-dioxo-2h-1,2,4-triazin-6-yl) phenazine-1-carbothioate |
403975 |
NSC719923 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Toddalin |
5351594 |
NSC76023 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Tributylgermyl 3-oxo-3-phenyl-propanoate |
16683249 |
NSC653557 |
|
sensitive |
|
|
|
|
hsa-miR-132-3p |
Tributyrin |
6050 |
NSC661583 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Tris(1,10-phenanthroline)lanthanum(iii)-trithiocyanate |
24202211 |
NSC632737 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Tris(1,10-phenanthroline)neodymium(iii)-trithiocyanate |
24202207 |
NSC632730 |
|
resistant |
|
|
|
|
hsa-miR-132-3p |
Doxorubicin |
31703 |
NSC123127 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-132-3p |
Doxorubicin |
31703 |
NSC123127 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (OV19, TOV21G, TOV112D, FUOV1, C13, OV2008, A2780CP, A2780S, IGROV1, T8, OVCAR5, IMCC3, A2008, OVCAR3, SKOV3, IOSER) |
hsa-miR-132-3p |
Verapamil |
2520 |
NSC272366 |
approved |
sensitive |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-132-3p |
Doxorubicin |
31703 |
NSC123127 |
approved |
sensitive |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (MCF-7) |
hsa-miR-132-3p |
Temozolomide |
5394 |
NSC362856 |
approved |
resistant |
|
High |
Glioblastoma |
cell line (U251MG, U251R, U87MG, M059K, M059J) |
hsa-miR-132-3p |
Imatinib |
5291 |
NSC743414 |
approved |
resistant |
|
High |
Myelogenous Leukemia |
cell line (MYL) |
hsa-miR-132-3p |
10-Hydroxycamptothecin |
97226 |
NSC107124 |
|
resistant |
|
High |
Gastric Cancer |
cell line (BGC823, SGC-7901, MGC-803, HGC-27, NCI-N87, AGS) |
hsa-miR-132-3p |
Paroxetine |
43815 |
|
approved |
sensitive |
|
High |
Normal |
lymphoblastoid cell line |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
High |
Non-Small Cell Lung Cancer |
cell line (H358, H1993) |
hsa-miR-132-3p |
Chemotherapy |
|
|
|
resistant |
|
High |
Osteosarcoma |
tissue |
hsa-miR-132-3p |
Fluorouracil |
3385 |
NSC19893 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-132-3p |
Gemcitabine |
60750 |
NSC613327 |
approved |
sensitive |
|
High |
Pancreatic Cancer |
cell line (PANC-1) |
hsa-miR-132-3p |
Gefitinib |
123631 |
NSC715055 |
approved |
resistant |
|
High |
Lung Adenocarcinoma |
cell line (A549) |
hsa-miR-132-3p |
Plx-4720 |
24180719 |
NSC757438 |
|
resistant |
|
High |
Thyroid Cancer |
cell line (8505c, BCPAP) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (A549) |
hsa-miR-132-3p |
Platinum |
23939 |
|
|
resistant |
|
High |
Ovarian Cancer |
tissue |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
Low |
Cervical Cancer |
tissue |
hsa-miR-132-3p |
Tamoxifen |
2733525 |
NSC180973 |
approved |
resistant |
|
High |
Breast Cancer |
cell line (TAMR1) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
Low |
Gastric Cancer |
cell line (MKN45, MKN28) |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
High |
Non-Small Cell Lung Cancer |
cell line (A549) |
hsa-miR-132-3p |
Temozolomide |
5394 |
NSC362856 |
approved |
resistant |
|
Low |
Glioblastoma |
cell line (U87MG) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
Low |
Nasopharyngeal Cancer |
cell line (CNE2) |
hsa-miR-132-3p |
Doxorubicin |
31703 |
NSC123127 |
approved |
resistant |
|
Low |
Breast Cancer |
tissue and cell line (MCF-7) |
hsa-miR-132-3p |
Ceritinib |
57379345 |
NSC776422 |
approved |
resistant |
|
High |
Non-Small Cell Lung Cancer |
cell line (H3122, H2228) |
hsa-miR-132-3p |
Panobinostat |
6918837 |
NSC761190 |
approved |
resistant |
|
High |
Non-Small Cell Lung Cancer |
cell line (H3122, H2228) |
hsa-miR-132-3p |
Trametinib |
11707110 |
NSC758246 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (2uM) |
hsa-miR-132-3p |
Trametinib |
11707110 |
NSC758246 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (200nM) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (1uM) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (500nM) |
hsa-miR-132-3p |
Trametinib |
11707110 |
NSC758246 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (500nM) |
hsa-miR-132-3p |
Trametinib |
11707110 |
NSC758246 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (1uM) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (2uM) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
High |
Melanoma |
cell line (WM266) (200nM) |
hsa-miR-132-3p |
Gefitinib |
123631 |
NSC715055 |
approved |
resistant |
|
High |
Non-Small Cell Lung Cancer |
tissue |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (SKVO3ip1, HeyA8) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780) |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (SKOV3) |
hsa-miR-132-3p |
Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) |
|
|
|
resistant |
|
High |
Metastatic Colorectal Cancer |
tissue |
hsa-miR-132-3p |
Trastuzumab |
|
|
|
resistant |
|
High |
Breast Cancer |
cell line (MDA‐MB‐231, SKBR3, HEK‐293T) |
hsa-miR-132-3p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
High |
Gastric Cancer |
cell line (MGC-803) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
Low |
Oral Cancer |
cell line (CAL-27) |
hsa-miR-132-3p |
Sorafenib |
216239 |
NSC747971 |
approved |
sensitive |
|
Low |
Hepatocellular Carcinoma |
cell line (MHCC97) |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (SKOV3ip1, HeyA8) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780CP20) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Ovarian Cancer |
cell line (A2780CIS) |
hsa-miR-132-3p |
Etoposide |
36462 |
NSC141540 |
approved |
sensitive |
|
Low |
Breast Cancer |
cell line |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
High |
Hypopharyngeal Cancer |
cell line (FaDu) |
hsa-miR-132-3p |
Antiepileptic Drug |
|
|
|
sensitive |
|
High |
Pediatric Epilepsy |
tissue |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
|
|
cell line (451Lu) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (SKVO3ip1) |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (HeyA8) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
|
|
cell line (LM17) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
resistant |
|
|
|
cell line (LM47) |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
|
|
cell line (BAS) |
hsa-miR-132-3p |
Tamoxifen+Fulvestrant |
|
|
|
sensitive |
|
|
|
cell line (LCC9) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CIS) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (CP20) |
hsa-miR-132-3p |
Ribavirin+Pegylated IFNa-2b |
|
|
|
resistant |
|
|
|
tissue (chronic hepatitis C) |
hsa-miR-132-3p |
Osimertinib |
71496458 |
NSC779217 |
approved |
sensitive |
|
|
|
cell line (H1975) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A2780) |
hsa-miR-132-3p |
Fluorouracil |
3385 |
NSC19893 |
approved |
resistant |
|
|
|
cell line (HCT15) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A2780) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
resistant |
|
|
|
cell line (RPMI2650) |
hsa-miR-132-3p |
Sunitinib |
5329102 |
NSC750690 |
approved |
sensitive |
|
|
|
tissue (CardA) |
hsa-miR-132-3p |
Paclitaxel |
36314 |
NSC125973 |
approved |
resistant |
|
|
|
cell line (SKOV3) |
hsa-miR-132-3p |
Tamoxifen |
2733525 |
NSC180973 |
approved |
resistant |
|
|
|
cell line (TamR1) |
hsa-miR-132-3p |
Vemurafenib |
42611257 |
NSC761431 |
approved |
sensitive |
|
|
|
cell line (LM16) |
hsa-miR-132-3p |
Ceritinib |
57379345 |
NSC776422 |
approved |
sensitive |
|
|
|
cell line (H3122) |
hsa-miR-132-3p |
Cisplatin |
5460033 |
NSC119875 |
approved |
sensitive |
|
|
|
cell line (A2780) |
hsa-miR-132-3p |
Cetuximab |
|
|
|
resistant |
|
|
|
tissue (colorectal carcinoma) |
hsa-miR-132-3p |
Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide/Methotrexate/Gemcitabine |
|
|
|
sensitive |
|
|
|
cell line (Bats-72) |
hsa-miR-132-3p |
Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide |
|
|
|
sensitive |
|
|
|
cell line (Bads-200) |